Cargando…

Cardioprotective effects of empagliflozin after ischemia and reperfusion in rats

The Sodium Glucose Co-Transporter-2 inhibitor, empagliflozin (EMPA), reduces mortality and hospitalisation for heart failure following myocardial infarction irrespective of diabetes status. While the findings suggest an inherent cardioprotective capacity, the mechanism remains unknown. We studied in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Seefeldt, Jacob Marthinsen, Lassen, Thomas Ravn, Hjortbak, Marie Vognstoft, Jespersen, Nichlas Riise, Kvist, Frederikke, Hansen, Jakob, Bøtker, Hans Erik
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8100147/ https://www.ncbi.nlm.nih.gov/pubmed/33953281 http://dx.doi.org/10.1038/s41598-021-89149-9

Ejemplares similares

Myocardial salvage by succinate dehydrogenase inhibition in ischemia–reperfusion injury depends on diabetes stage in rats
por: Tonnesen, Pernille Tilma, et al.
Publicado: (2021)

Differences in intrinsic aerobic capacity alters sensitivity to ischemia-reperfusion injury but not cardioprotective capacity by ischemic preconditioning in rats
por: Hjortbak, Marie Vognstoft, et al.
Publicado: (2020)

Cardioprotective effect of succinate dehydrogenase inhibition in rat hearts and human myocardium with and without diabetes mellitus
por: Jespersen, Nichlas Riise, et al.
Publicado: (2020)

Impact of hyperglycemia on myocardial ischemia–reperfusion susceptibility and ischemic preconditioning in hearts from rats with type 2 diabetes
por: Kristiansen, Steen Buus, et al.
Publicado: (2019)

Influence of strain, age, origin, and anesthesia on the cardioprotective efficacy by local and remote ischemic conditioning in an ex vivo rat model
por: Lassen, Thomas Ravn, et al.
Publicado: (2021)

Cardioprotective effect of combination therapy by mild hypothermia and local or remote ischemic preconditioning in isolated rat hearts
por: Hjortbak, Marie V., et al.
Publicado: (2021)

Impact of Administration Time and Kv7 Subchannels on the Cardioprotective Efficacy of Kv7 Channel Inhibition
por: Hansen, Jan, et al.
Publicado: (2020)

Influence of diabetes mellitus duration on the efficacy of ischemic preconditioning in a Zucker diabetic fatty rat model
por: Hjortbak, Marie Vognstoft, et al.
Publicado: (2018)

Effects of hypoglycemia on myocardial susceptibility to ischemia–reperfusion injury and preconditioning in hearts from rats with and without type 2 diabetes
por: Pælestik, Kim B., et al.
Publicado: (2017)

Hyperpolarized (13)C MRI Reveals Large Changes in Pyruvate Metabolism During Digestion in Snakes
por: Hansen, Kasper, et al.
Publicado: (2022)

Mitochondrial Structure and Function in the Metabolic Myopathy Accompanying Patients with Critical Limb Ischemia
por: Groennebaek, Thomas, et al.
Publicado: (2020)

Ischemia-Selective Cardioprotection by Malonate for Ischemia/Reperfusion Injury
por: Prag, Hiran A., et al.
Publicado: (2022)

Cardiovascular Effects of Treatment With the Ketone Body 3-Hydroxybutyrate in Chronic Heart Failure Patients
por: Nielsen, Roni, et al.
Publicado: (2019)

Empagliflozin protects against renal ischemia/reperfusion injury in mice
por: Wang, Qifeng, et al.
Publicado: (2022)

Interaction of Cardiovascular Nonmodifiable Risk Factors, Comorbidities and Comedications With Ischemia/Reperfusion Injury and Cardioprotection by Pharmacological Treatments and Ischemic Conditioning
por: Ferdinandy, Péter, et al.
Publicado: (2023)

Ketone body 3-hydroxybutyrate elevates cardiac output through peripheral vasorelaxation and enhanced cardiac contractility
por: Homilius, Casper, et al.
Publicado: (2023)

Cyclic Hypoxia Conditioning Alters the Content of Myoblast-Derived Extracellular Vesicles and Enhances Their Cell-Protective Functions
por: Yan, Yan, et al.
Publicado: (2021)

Untargeted metabolomics reveals a mild impact of remote ischemic conditioning on the plasma metabolome and α-hydroxybutyrate as a possible cardioprotective factor and biomarker of tissue ischemia
por: Laursen, Mia Roest, et al.
Publicado: (2017)

Cardioprotective Effect of Cilostazol on Ischemia-Reperfusion Injury Model
por: Sahin, Mazlum, et al.
Publicado: (2022)

Influence of Cardiovascular Risk Factors, Comorbidities, Medication Use and Procedural Variables on Remote Ischemic Conditioning Efficacy in Patients with ST-Segment Elevation Myocardial Infarction
por: Pryds, Kasper, et al.
Publicado: (2019)

Cardioprotective Effects of Quercetin in Cardiomyocyte under Ischemia/Reperfusion Injury
por: Chen, Yi-Wen, et al.
Publicado: (2013)

Cardioprotective Properties of Omecamtiv Mecarbil against Ischemia and Reperfusion Injury
por: Stroethoff, Martin, et al.
Publicado: (2019)

Somatostatin and Its Receptors in Myocardial Ischemia/Reperfusion Injury and Cardioprotection
por: Vörös, Imre, et al.
Publicado: (2021)

The Role of O-GlcNAcylation for Protection against Ischemia-Reperfusion Injury
por: Jensen, Rebekka Vibjerg, et al.
Publicado: (2019)

Empagliflozin protects the heart against ischemia/reperfusion-induced sudden cardiac death
por: Hu, Zhaoyang, et al.
Publicado: (2021)

Veno-occlusive unloading of the heart reduces infarct size in experimental ischemia–reperfusion
por: Hansen, Esben Søvsø Szocska, et al.
Publicado: (2021)

Cardioprotective effects of lixisenatide in rat myocardial ischemia-reperfusion injury studies
por: Wohlfart, Paulus, et al.
Publicado: (2013)

Cardioprotective Effect of Betulinic Acid on Myocardial Ischemia Reperfusion Injury in Rats
por: Xia, Anzhou, et al.
Publicado: (2014)

Cardioprotection against Ischemia/Reperfusion by Licochalcone B in Isolated Rat Hearts
por: Han, Jichun, et al.
Publicado: (2014)

Cardioprotection provided by Echinatin against ischemia/reperfusion in isolated rat hearts
por: Tian, Xing-han, et al.
Publicado: (2016)

Cardioprotective effects of Achillea wilhelmsii on the isolated rat heart in ischemia–reperfusion
por: Mahmoudabady, M., et al.
Publicado: (2017)

Novel Molecular Targets Participating in Myocardial Ischemia-Reperfusion Injury and Cardioprotection
por: Liu, Nan-Bo, et al.
Publicado: (2019)

Cardioprotective effect of sonic hedgehog ligand in pig models of ischemia reperfusion
por: Ghaleh, Bijan, et al.
Publicado: (2020)

Empagliflozin attenuates cardiac microvascular ischemia/reperfusion injury through improving mitochondrial homeostasis
por: Zou, Rongjun, et al.
Publicado: (2022)

Extensive Simulated Diving Aggravates Endothelial Dysfunction in Male Pro-atherosclerotic ApoE Knockout Rats
por: Berenji Ardestani, Simin, et al.
Publicado: (2020)

Cardioprotective effects of short-term empagliflozin treatment in db/db mice
por: Radlinger, Bernhard, et al.
Publicado: (2020)

Cardioprotective effects of Guanxinshutong (GXST) against myocardial ischemia/ reperfusion injury in rats
por: Liang, Zhuo, et al.
Publicado: (2012)

Glycation abolishes the cardioprotective effects of albumin during ex vivo ischemia‐reperfusion
por: Mapanga, Rudo F., et al.
Publicado: (2017)

Indolylmaleimide Derivative IM-17 Shows Cardioprotective Effects in Ischemia-Reperfusion Injury
por: Dodo, Kosuke, et al.
Publicado: (2018)

Cardioprotective effects of sinomenine in myocardial ischemia/reperfusion injury in a rat model
por: Lu, Changhong, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_g8h7rmk8o4k2uii8jfa3ku096j